Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Income Statement [Abstract]
REVENUES	$ 1,529	$ 1,511
COST OF REVENUES	1,237	1,219
GROSS PROFIT	292	292
OPERATING EXPENSES:
Research and development	4,059	2,625
Selling and marketing	2,750	1,237
General and administrative	4,943	3,844
Total operating expenses	11,752	7,706
LOSS FROM OPERATIONS	(11,460)	(7,414)
FINANCIAL INCOME, net	294	382
NET LOSS	$ (11,166)	$ (7,032)
NET LOSS PER SHARE - basic	$ (0.22)	$ (0.21)
NET LOSS PER SHARE - diluted	$ (0.22)	$ (0.21)
WEIGHTED AVERAGE NUMBER OF ORDINARY SHARES USED IN COMPUTING NET LOSS PER SHARE - basic	49,993,509	34,242,976
WEIGHTED AVERAGE NUMBER OF ORDINARY SHARES USED IN COMPUTING NET LOSS PER SHARE - diluted	49,993,509	34,242,976